Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
BOTHELL, WA--(Marketwire - March 16, 2010) - MDRNA, Inc. -- (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, today announced that it will host a conference call...
-
BOTHELL, WA--(Marketwire - March 15, 2010) - MDRNA, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, today announced enhanced efficacy for tumor reduction when...
-
BOTHELL, WA--(Marketwire - March 8, 2010) - MDRNA, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, today announced that J. Michael French, MDRNA's President and...
-
BOTHELL, WA--(Marketwire - February 8, 2010) - MDRNA, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, today announced that its lead delivery system formulation...
-
BOTHELL, WA--(Marketwire - February 8, 2010) - MDRNA, Inc. (NASDAQ: MRNA) announced that it received a letter on February 5, 2010 from The NASDAQ Stock Market, Inc. notifying the Company that, as a...
-
BOTHELL, WA--(Marketwire - February 1, 2010) - MDRNA, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, today announced that it will present at the 12th Annual BIO CEO...
-
BOTHELL, WA--(Marketwire - January 26, 2010) - MDRNA, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, today announced that the State Intellectual Property Office of...
-
BOTHELL, WA--(Marketwire - January 21, 2010) - MDRNA, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, today announced that the European Patent Office intends to...
-
BOTHELL, WA--(Marketwire - January 19, 2010) - MDRNA, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, today announced the presentation of data highlighting the...
-
BOTHELL, WA--(Marketwire - January 14, 2010) - MDRNA, Inc. (NASDAQ: MRNA) announced today that it has entered into a definitive agreement with investors to raise gross proceeds of $5.5 million...